The National Heart, Lung, and Blood Institute (NHLBI) awarded Medfree Inc., a minority-owned small business, a $275,530 Project Grant under CFDA 93.837 (Cardiovascular Diseases Research) to develop a novel 12F self-closing mitral valve repair system for percutaneous treatment of moderate to severe mitral regurgitation. The project aims to create a simpler, easier-to-use device that improves upon the current market-leading MitraClip device by leveraging the proven transcatheter edge-to-edge repair (TEER) technique. Medfree has already completed preclinical GLP studies in a porcine model with outstanding results and is now seeking funds to support early feasibility studies and first-in-human clinical trials for this innovative cardiovascular medical device.
Generated 3/4/25, 7:47 AM